Compare AbbVie Inc (ABBV) vs Utilities Select Sector SPDR Fund (XLU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbbVie Inc vs Utilities Select Sector SPDR Fund — how do they compare? AbbVie Inc trades at $250.55 (market cap $438.19B), while Utilities Select Sector SPDR Fund trades at $43.62. The key difference: AbbVie Inc pays a 2.79% dividend while Utilities Select Sector SPDR Fund pays none, and AbbVie Inc is trading nearer its 52-week high, Utilities Select Sector SPDR Fund nearer its low. Which is the better fit depends on your goals.
| ABBV | XLU | |
|---|---|---|
Market Cap | $438.19B | — |
Sector | Health | — |
52-Week High | $263.58 | $47.73 |
52-Week Low | $197.38 | $41.31 |
Enterprise Value | $502.45B | — |
Dividend Yield | 2.79% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AbbVie (ABBV) trades at $250.50, up 1.81% on the day, with a bullish technical signal and strong analyst consensus. Recent earnings beats and robust revenue growth, driven by Skyrizi and Rinvoq, highlight fundamental strength. The stock is supported by a 70.73% buy rating from analysts and a consensus price target of $281.33, with positive news flow from clinical trial results and institutional buying.
The outlook remains positive with earnings growth and dividend sustainability, though risks include patent cliffs in the 2030s and competitive pressures. Valuation metrics like a P/E of 70.05 suggest premium pricing, but operational cash flow of $19.03B in 2025 supports continued investment and shareholder returns.
XLU trades at $43.61, up 0.51% with a bearish technical signal from moving averages. The ETF benefits from AI-driven power demand, with recent news highlighting increased call option activity and sector momentum. Support sits at $42-43 while resistance is at $44-45. The utilities sector is gaining attention as AI data centers drive electricity consumption growth.
The outlook remains mixed with technical weakness offset by strong sector fundamentals. AI power demand creates growth opportunities, but regulatory risks and interest rate sensitivity pose challenges. The ETF's defensive income characteristics provide stability amid market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AbbVie Inc
AbbVie is a pharmaceutical company with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.
Read more on ABBV →About Utilities Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes securities of companies from the following industries: electric utilities; water utilities; multi-utilities; independent power and renewable electricity producers; and gas utilities. The fund is non-diversified.
Read more on XLU →
